These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 18220762)

  • 1. Aggresome formation and neurodegenerative diseases: therapeutic implications.
    Olzmann JA; Li L; Chin LS
    Curr Med Chem; 2008; 15(1):47-60. PubMed ID: 18220762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway.
    Olzmann JA; Chin LS
    Autophagy; 2008 Jan; 4(1):85-7. PubMed ID: 17957134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin-mediated ubiquitin signalling in aggresome formation and autophagy.
    Chin LS; Olzmann JA; Li L
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):144-9. PubMed ID: 20074049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains.
    Hao R; Nanduri P; Rao Y; Panichelli RS; Ito A; Yoshida M; Yao TP
    Mol Cell; 2013 Sep; 51(6):819-28. PubMed ID: 24035499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance.
    Yung C; Sha D; Li L; Chin LS
    Mol Neurobiol; 2016 Nov; 53(9):6270-6287. PubMed ID: 26563499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation.
    Rodriguez-Gonzalez A; Lin T; Ikeda AK; Simms-Waldrip T; Fu C; Sakamoto KM
    Cancer Res; 2008 Apr; 68(8):2557-60. PubMed ID: 18413721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggresomes, inclusion bodies and protein aggregation.
    Kopito RR
    Trends Cell Biol; 2000 Dec; 10(12):524-30. PubMed ID: 11121744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic dynein/dynactin mediates the assembly of aggresomes.
    Johnston JA; Illing ME; Kopito RR
    Cell Motil Cytoskeleton; 2002 Sep; 53(1):26-38. PubMed ID: 12211113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases.
    Cristofani R; Crippa V; Rusmini P; Cicardi ME; Meroni M; Licata NV; Sala G; Giorgetti E; Grunseich C; Galbiati M; Piccolella M; Messi E; Ferrarese C; Carra S; Poletti A
    Autophagy; 2017 Aug; 13(8):1280-1303. PubMed ID: 28402699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.
    Taylor JP; Tanaka F; Robitschek J; Sandoval CM; Taye A; Markovic-Plese S; Fischbeck KH
    Hum Mol Genet; 2003 Apr; 12(7):749-57. PubMed ID: 12651870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
    Li X; Liu H; Fischhaber PL; Tang TS
    Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misfolded polypeptides are selectively recognized and transported toward aggresomes by a CED complex.
    Park J; Park Y; Ryu I; Choi MH; Lee HJ; Oh N; Kim K; Kim KM; Choe J; Lee C; Baik JH; Kim YK
    Nat Commun; 2017 Jun; 8():15730. PubMed ID: 28589942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3 protein targets misfolded chaperone-associated proteins to aggresomes.
    Xu Z; Graham K; Foote M; Liang F; Rizkallah R; Hurt M; Wang Y; Wu Y; Zhou Y
    J Cell Sci; 2013 Sep; 126(Pt 18):4173-86. PubMed ID: 23843611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between translation and the aggresome-autophagy pathway.
    Park Y; Park J; Kim YK
    Autophagy; 2018; 14(6):1079-1081. PubMed ID: 28837386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperone-mediated 26S proteasome remodeling facilitates free K63 ubiquitin chain production and aggresome clearance.
    Nanduri P; Hao R; Fitzpatrick T; Yao TP
    J Biol Chem; 2015 Apr; 290(15):9455-64. PubMed ID: 25713068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3 and aggresome formation: implications in neurodegenerative diseases.
    Jia B; Wu Y; Zhou Y
    Prion; 2014; 8(2):173-7. PubMed ID: 24549097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.